BSEAGM/EGM29 Sept 2026 · 29 Sept 2026, 02:38 pm

Outcome and Proceedings of 32nd AGM of the Company held on 29th September, 2026

Advik Laboratories Ltd · 531686

✦ AI SummaryResults

The 32nd Annual General Meeting (AGM) of Advik Laboratories Ltd was held on September 29, 2026, where the company's audited financial statements for the year ended March 31, 2026, were adopted, and various resolutions were passed, including the re-appointment of the statutory auditors and the appointment of an independent director.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Advik Laboratories Ltd - 531686 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Attachments (1)

📄

ae74f6ac-ed5a-4b86-b850-d6dac8592648.pdf

pdf

Download →
View document text
MPS PHARMAA LIMITED (Formerly Advik Laboratories Limited) Dated: 29th September, 2026 The Manager (Listing), Bombay Stock Exchange Limited, 01st Floor, P. J. Towers, Dalal Street, Mumbai - 400001 Sub: Outcome and Proceedings of 32nd Annual General Meeting of the Company held on 29th September, 2026 Ref: BSE Scrip Code 531686; ASE Scrip Code- 01636 (ADVIK LABO); ISIN No: INE537C01019 Dear Sir, We wish to inform you that the 32nd Annual General Meeting of the Company was duly held on Tuesday, 29th September, 2026 and the business mentioned in the notice was duly transacted. In this regard, please find mentioned hereinbelow the proceedings of the 32nd Annual General Meeting of the Company held on 29th September, 2026 at 9:30 A.M for your kind reference and records: Mr. Peeyush Kumar Aggarwal was elected as the Chairman of the meeting by show of hands. The Chairman welcomed the Members of the Company and commenced the proceedings. The requisite quorum was present and the Meeting was called to order. The Chairman introduced the Directors, Management Committee Members and the Invitees present at the meeting. The Chairman then informed that the Notice of the AGM along with the Audited Standalone Financial Statements of the Company for the Financial Year ended March 31, 2026, and the report of Board of Directors thereon, were already circulated electronically within the required timeframe to those shareholders whose email ids are registered with the Registrar and Share Transfer Agent (RTA) or Depository Participant. Furthermore, it was also informed that the Company had dispatched a letter to shareholders whose email addresses were not registered with the Registrar and Transfer Agent or Depository Participant, which included a web link to access the Annual Report on the Company's website. The Chairman delivered his speech and the Notice convening the meeting was taken as read with the permission of the members present. Thereafter, the Chairman read the Auditors’ Report and requested the members to raise their queries. He clarified the queries raised by the shareholders to their satisfaction. The Chairman informed the members present that statutory books were kept open for inspection and the members desiring of inspecting the statutory books may inspect the same. The Chairman further informed the Members present at the meeting that the remote e-Voting has been closed on 28th September, 2026 at 05.00 P.M. and requested the members who have not exercised their vote through e-Voting to cast their votes by ballot on the following items of business included in the Notice of 32nd Annual General Meeting and the members were further informed by the Chairman that Mr. Kundan Agarwal (FCS: CIN No. : L74899HR1994PLC038300 Corporate Office : 703, Arunachal building 19, Barakhamba Road, Connaught Place, New Delhi 110001 Phones: 011-42424884, 43571040-45, Fax: 011-43571047 Regd. Office & Factory: 138. Roz-Ka-Meo Industrial Area, Sohna - 122103 (Distt.Mewat), Haryana Phones: 0124-2362471 Email: info@mpspharmaa.com Website: www.mpspharmaa.com MPS PHARMAA LIMITED (Formerly Advik Laboratories Limited) 8325) from Kundan Agrawal & Associates, Practicing Company Secretaries, is appointed as a Scrutinizer for remote e-voting & polling process. The Chairman further informed that the Company had taken all requisite steps to enable members to participate and vote on the items of the businesses considered at the meeting. Thereafter, the following resolutions set out in the Notice convening the AGM were read by the Chairman of the meeting: S. NO. PARTICULARS OF BUSINESS NATURE OF RESOLUTION Ordinary Business: 1. Adoption of Audited Financial Statements of the Ordinary company including the Balance Sheet of the Company as at 31st March, 2026 and the Statement of Profit and Loss of the Company for the financial year ended 31st March, 2026 together with the Cash Flow Statement & other Annexures thereof and the Report of the Board of Directors and Auditors thereon. 2. To appoint a Director in place of Mr. Ram Niwas Ordinary Sharma (DIN:08427985), who is liable to retire by rotation and being eligible, offers himself for re- appointment pursuant to the provisions of Section 152 of the Companies Act, 2013. 3. Re-appointment of M/s Nemani Garg Agarwal & Co., Ordinary Chartered Accountants as the Statutory Auditors of the Company. Special Business: 4. Approval for Related Party Transactions under Section Ordinary 188 of the Companies Act, 2013 and Regulation 23 Of SEBI (LODR) Regulations, 2015. 5. Appointment of Ms. Anchal Goyal (DIN 10751205) as Special an Independent Director of the Company. 6. Approval Of Transactions Under Section 185 Of The Special Companies Act, 2013 The shareholders present, who have not casted their vote through remote e-voting, casted their vote in Ballot Form provided to them at the beginning of the Annual General Meeting and put their ballot forms in the Ballot Box duly locked and sealed by the Scrutinizer, in the presence of the Scrutinizer and Chairman and other persons. The Chairman then informed the members that the combined results of the voting on the resolutions, along with the Scrutinizer’s Report, would be intimated to the BSE Limited and ASE Limited & to the Registrar of Companies, NCT of Delhi & Haryana and that they would also be placed on the Company’s website and on the website of National Securities Depository Limited within 02 working days of the AGM. CIN No. : L74899HR1994PLC038300 Corporate Office : 703, Arunachal building 19, Barakhamba Road, Connaught Place, New Delhi 110001 Phones: 011-42424884, 43571040-45, Fax: 011-43571047 Regd. Office & Factory: 138. Roz-Ka-Meo Industrial Area, Sohna - 122103 (Distt.Mewat), Haryana Phones: 0124-2362471 Email: info@mpspharmaa.com Website: www.mpspharmaa.com MPS PHARMAA LIMITED (Formerly Advik Laboratories Limited) Before concluding, the Chairman thanked all the shareholders for attending this meeting and extending their co- operation. Further, he also thanked all the employees for their trust and generous support and declared the meeting closed at 10:15 A.M. This intimation is given pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015. You are hereby requested to take the aforesaid proceedings of the 32nd Annual General Meeting of the Company in your records. Thanking You. Yours Truly, For MPS Pharmaa Limited (Formerly known as Advik Laboratories Limited ) Pooja Chuni Company Secretary The Manager (Listing) Ahmedabad Stock Exchange Limited 01st Floor, Kamdhenu Complex, Opp. Sahajanand College, Panjara Pole, Ambawadi, Ahmedabad – 380015 CIN No. : L74899HR1994PLC038300 Corporate Office : 703, Arunachal building 19, Barakhamba Road, Connaught Place, New Delhi 110001 Phones: 011-42424884, 43571040-45, Fax: 011-43571047 Regd. Office & Factory: 138. Roz-Ka-Meo Industrial Area, Sohna - 122103 (Distt.Mewat), Haryana Phones: 0124-2362471 Email: info@mpspharmaa.com Website: www.mpspharmaa.com